Executive Briefing: How to Address Addiction
Kelly Clark, MD, MBA, DFASAM
President, American Society of Addiction Medicine
Penny Mills, MBA
Executive Vice-president & CEO, American Society of Addiction Medicine
Addiction is costly to our nation, exacting more than $740 billion annually in costs related to lost work productivity, healthcare, and crime. Studies have documented the effectiveness of evidence-based treatment with total savings related to healthcare, reduced drug-related crimes and criminal justice exceeding costs by a ratio of 12 to 1. Too often, however, addiction goes either untreated or inappropriately treated with high cost and ineffective care delivery.
Dr. Kelly Clark and Penny Mills will deliver a briefing for senior executives, healthcare providers, and employers interested in reducing their healthcare costs and improving their workforce effectiveness, by examining possible solutions to the vast disconnect between what we know works and what we are too often doing.
This executive briefing will examine the following:
- Why are employers paying so much for treatment and getting poor outcomes?
- What is evidence- based care and how can employers ensure their employees are obtaining it when they need it?
- Why do physicians and other clinicians lack knowledge, training, and skills to address substance use and provide good patient care? What steps must be taken, and resources garnered to solve this issue?
- Prevention and treatment of addiction are poorly integrated into our healthcare system and many people are unaware of the current, though limited, standards, guidelines and performance measures to assess outcomes and improve the quality of addiction care. How can legitimate quality metrics and performance measures be better utilized, and misleading marketing metrics countered to ensure cost-effective, quality care?
- Addiction services should be covered and provided like other medical services under a variety of parity laws. However, many employers and health plans find available networks insufficient for the high quality and they would like to access.
- What can be done to ensure that addiction services are covered and provided like any other medical service, under medical necessity determinations based on quality?
- Often times, employees, patients, and family members are uncomfortable talking about the disease of addiction and seeking help from their clinicians. How can companies address stigma in the workplace and take steps to fight stigma as a barrier to treatment and educate their associates on what to look for in quality treatment?
The briefing will conclude with an open discussion of how associations and private/public companies can work together to solve the issues of addiction in the workplace and the related inappropriately high costs of care.
This briefing is open to all HLTH attendees and media. Please fill out the form below and a personal invitation will be sent to confirm your registration.